Office of Research
Scientific Review Committees (SRC) are therapeutic-specific and meet on a monthly basis. Each SRC maintain separate deadlines for submission. SRC review is required for all therapeutic, behavioral, laboratory, and secondary data studies regardless of phase or funding. Studies must receive approval of the therapeutic-specific SRC prior to IRB submission. To submit a study for SRC review, the therapeutic-specific SRC and contact information are as follows:
Studies of therapeutic areas outside of the established SRCs should be submitted to the ORS who will request review by one of the therapeutic SRCs. To submit a study for review outside of the established therapeutic SRCs, please email the study related documents to email@example.com.
Once a study is approved, the SRC submits the required documentation to the ORS for IRB submission and pre-award negotiations of the clinical trial agreement and budget.